Acasti Pharma Inc. (ACST)
ACSTPrice: $3.37
Fair Value: 🔒
🔒score
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval,... more
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of... more
Description
Shares
| Market Cap | $34.17M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | CA | CEO | Prashant Kohli |
| IPO Date | 2012-02-07 | CAGR | — |
| Employees | 32 | Website | www.acastipharma.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ACST chart loading...
Fundamentals
Technicals
| Enterprise Value | $32.23M | P/E Ratio | -2.36 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 5167.15 | P/B Ratio | 0.75 |
| P/CF Ratio | -3.63 | P/FCF Ratio | -3.15 |
| EPS | $-1.43 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | -0.12% |
| Operating Margin | -1851% | Profit Margin | -1289.12% |
| ROE | -0.17% | ROA | -0.15% |
| ROCE | -0.22% | Current Ratio | 8.87 |
| Quick Ratio | 8.87 | Cash Ratio | 8.64 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | -1.09 | Piotroski Score | 3 |